Pfizer CentreOne® is a global CDMO embedded within Pfizer and specializes in small molecule API synthesis.
Pfizer CentreOne® is a global contract development and manufacturing organisation (CDMO) embedded within Pfizer and a leading supplier of speciality active pharmaceutical ingredients (APIs).
Our global manufacturing network includes more than 35 sites across six continents. Backed by Pfizer resources, we deliver technical expertise, global regulatory support and long-term supply.
Working together with our customers, we combine our knowledge with open dialogue to solve challenges, as well as intelligent collaboration with Pfizer CentreOne.
We focus on custom API synthesis, sterile injectable fill-finish and highly potent oral solid dose and are a leading supplier of steroid and hormone APIs and intermediates.
For more than 40 years, we have manufactured complex compounds for our biopharmaceutical partners, guiding their drugs safely from development through commercialization.
The value of the embedded CDMO model
Your molecule is manufactured in the same facilities that produce Pfizer’s drugs, with the same vigilance and care.
Throughout the development process, you will work with a dedicated programme manager and a core team of experts who deeply understand your molecule and business goals.
Should challenges arise that require specialised knowledge, labs or technology, they can harness literally a world of Pfizer resources on your behalf, while serving as your advocate across the broader Pfizer organization.
Putting Pfizer’s global experience to work for you.
Pfizer CentreOne has manufacturing facilities in the United States, Europe and Asia Pacific that have been carefully selected to meet your needs.
Our practical regulatory and commercial experience spans more than 100 countries around the world. We help you not only launch your compound but select packaging and lifecycle management strategies that work most successfully in your chosen markets.
Services and capabilities
Custom API synthesis
- Able to perform almost any kind of chemistry you need, we provide complex organic synthesis; small-molecule fermentation and bioprocessing up to 150,000l scale; and continuous process optimisation.
Sterile injectable fill-finish
- Our expertise includes complex biologics, controlled substances and lyophilization. Starting as early as Phase II, we specialise in helping our biopharma partners – from small biotechs to global companies – successfully develop, scale-up and commercialize their novel drugs.
Highly potent oral solid dose
- We have deep experience handling highly potent or highly active drugs. At our state-of-the-art segregated facilities, we partner with you to scale up and safely manufacture your compound.
Specialty APIs and intermediates
Known for our steroids and hormones, we also offer select antibiotics. In addition to a Pfizer-quality molecule, you can count on a quick response to regulator inquiries when they arise.
Pfizer CentreOne® is a global CDMO embedded within Pfizer and a leader in sterile injectables. Working with our customers, we combine our technical and commercial knowledge with open dialogue to solve your challenges.
Pfizer CentreOne® has been a leading provider of speciality APIs and intermediates for more than 50 years. Our Kalamazoo, Michigan site produces APIs and intermediates using Pfizer quality standards – the same that Pfizer uses for its own branded medicines.
EnvieroTM progesterone is the first compound launched from Pfizer CentreOne’s Enviero green-chemistry program and is being adopted across Pfizer providing the latest in lower environmental impact products for patients around the world.
Pfizer CentreOne® is a global CDMO embedded within Pfizer. Equipped with the most advanced technologies, Pfizer CentreOne has rich experience in biologic products.
Pfizer CentreOne® is a global CDMO embedded within Pfizer and has a global network ready to deliver end-to-end analytical and manufacturing expertise.
We take partner IP protection very seriously. At Pfizer CentreOne, we’ve been manufacturing partner products alongside our own for decades.
Demand for drugs and therapeutics of all kinds is growing with the globalisation of pharmaceutical-based medicine.
Development of novel custom active pharmaceutical ingredients (APIs) is increasingly turned over to outsourced partners who have become the primary drivers of the product’s overall development and go-to-market strategy. With hundreds of potential partners that drug owners can choose from to develop and manufacture custom API, choosing the best partner can be a challenging task.
The countdown on adherence to global serialisation is well underway.
We are sorry that you were not able to attend the webinar titled: Pfizer CentreOne - Coating: Curing Your Complex Oral Solid Dose (OSD) Challenges.
Pfizer CentreOne today announced the introduction of Enviero™ progesterone into the API marketplace.
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, has announced that it has been named a recipient of Life Science Leader’s 2017 CMO Leadership Awards, now in its sixth year.
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, today announced that it has expanded its fill-finish services to its Kalamazoo, Michigan (United States), site.
Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, today announced that it has grown its service portfolio to include contract manufacturing of highly potent solid oral dose medicines.
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, today announced that it is now offering services in Nagoya, Japan.
235 E. 42nd Street
New York 10017
United States of America